Squamous Cell Cancer of Head and Neck (SCCHN) Clinical Trials

10 clinical trials for Squamous Cell Cancer of Head and Neck (SCCHN) across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) — RECRUITING · PHASE1
• Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE3
• Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer — RECRUITING · NA
• Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy — RECRUITING · NA
• Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
• A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer — TERMINATED · PHASE1
• Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck — NOT_YET_RECRUITING · NA
• First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours — COMPLETED · PHASE1
• IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors — OTHER · PHASE1

Refine this search